Ensaio em fase de recrutamento = ; Ensaio a decorrer = ; Ensaio concluído = ; Financiado por um membro do IRDiRC = ; Membro de uma ERN =

Ensaio (s) clínico (s) nacional (is)

ALEMANHA

Hamburg
HAMBURG

Calciphyx: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of SNF472 When Added to Background Care for the Treatment of Calciphylaxis - DE

DaVita Deutschland AG

Mais detalhes

BELGICA

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Calciphyx: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of SNF472 When Added to Background Care for the Treatment of Calciphylaxis - BE

Erasme Hospital - ULB

Néphrologie

Mais detalhes

ESPANHA

Madrid
ADDRESS: NOT PROVIDED - ES

Calciphyx: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of SNF472 When Added to Background Care for the Treatment of Calciphylaxis - ES (completed)

Institution: Information not provided - ES

Mais detalhes

FRANCA

AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of SNF472 When Added to Background Care for the Treatment of Calciphylaxis -FR

Institution: Information not provided - FR

Mais detalhes